Beryl Drugs Ltd

NSE: BERLDRG · BSE: 524606 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.55
Market cap: ₹12.96 Cr
Revenue (annual): ₹18.82 Cr
Net profit (annual): ₹0.42 Cr
P/E (TTM): 20.8×Sector 47.3×
Promoter holding: 27.82%+0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Outcome 4 Board Meeting Date 4 Annual General Meeting 4 Promoter Buying 3 Other Announcement 3 Financial Results 3 Debt & Borrowing 1 Capacity Expansion 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

19 Aug 2026 11:17 IST BSE

Promoter Buying

Beryl Drugs Promoter Buying

Sudhir Sethi, a promoter of Beryl Drugs Limited, acquired 3,000 equity shares via market transactions. This acquisition increases the promoter's total stake from 10.08% to 10.14%.

Read the filing ↗

29 Jun 2026 13:02 IST BSE

Promoter Buying

Beryl Drugs Promoter Buying

Promoter Sudhir Sethi acquired 6,950 shares of Beryl Drugs Ltd via market transactions. This increases the promoter's stake by 0.14% to a total of 10.055%.

Read the filing ↗

8 Jun 2026 13:02 IST BSE

Promoter Buying

Beryl Drugs Promoter Buying

Promoter Mr. Sudhir Sethi acquired 1,992 equity shares of Beryl Drugs Limited through open market transactions. The purchase increases his total stake to 9.75%.

Read the filing ↗